Compare WEN & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WEN | PAHC |
|---|---|---|
| Founded | 1969 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2001 | 2014 |
| Metric | WEN | PAHC |
|---|---|---|
| Price | $7.64 | $35.83 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 22 | 4 |
| Target Price | $8.84 | ★ $41.25 |
| AVG Volume (30 Days) | ★ 8.9M | 202.0K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 8.28% | 0.91% |
| EPS Growth | N/A | ★ 104.20 |
| EPS | 0.29 | ★ 2.43 |
| Revenue | ★ $2,176,891,000.00 | $833,350,000.00 |
| Revenue This Year | $2.26 | $17.03 |
| Revenue Next Year | $0.94 | $3.82 |
| P/E Ratio | $26.00 | ★ $15.14 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $6.07 | $28.25 |
| 52 Week High | $10.12 | $60.08 |
| Indicator | WEN | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 40.67 | 51.17 |
| Support Level | $7.12 | $36.31 |
| Resistance Level | $8.26 | $37.92 |
| Average True Range (ATR) | 0.32 | 1.58 |
| MACD | -0.16 | -0.06 |
| Stochastic Oscillator | 2.34 | 28.10 |
The Wendy's Co is engaged in operating, developing, and franchising a system of distinctive quick-service restaurants serving high-quality food. The company operates through Wendy's U.S., Wendy's International, and Global Real Estate & Development. Wendy's U.S. and Wendy's International include the operation and franchising of restaurants and derive revenues from sales at company-operated restaurants, as well as royalties, franchise fees, and advertising fund collections from franchised restaurants. Global Real Estate & Development includes real estate activities for owned and leased sites that are leased or subleased to franchisees and includes the company's share of income from its Canadian restaurant real estate joint venture.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.